Skip to content
Screener

CareDx CDNA Common Stock

Common Stock at other companies

Natera, Inc. logo
Natera, Inc.NTRA
750M+5,357,043%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
$394.95M+7.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$10K+11.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$4K+33.3%
NeoGenomics logo
NeoGenomicsNEO
$130K+1.6%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$11K-92.5%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.42B+279%
Enterprise value$2.36B+295%
P/S5.9×+4.0×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock: $0.001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025
Common stock: $0.001 par value; 100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 51,274,651 and 50,916,644 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively5150
Additional paid-in capital1,052,3061,043,925
Accumulated other comprehensive loss(6,272)(5,515)
Accumulated deficit(732,550)(735,359)
Total stockholders’ equity313,535303,101

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's common stock?
CareDx (CDNA) reported common stock of 100M in Q1 2026.
How has CareDx's common stock changed year-over-year?
CareDx's common stock decreased by 0.0% year-over-year, from 100M to 100M.
What is the long-term trend for CareDx's common stock?
Over 5 years (2020 to 2025), CareDx's common stock has grown at a 359.2% compound annual growth rate (CAGR), from 49K to 100M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about CareDx's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude